EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success

Aya Ludin, Georgia L Stirtz, Asaf Tal, Ajit J Nirmal, Kathleen L Pfaff, Michael Manos, Naomi Besson, Nebiyat Eskndir, Billie Porter, Stephanie M Jones, Hannah M Faulkner, Qiyu Gong und 32 weitere

Cell · 2025

DOI: 10.1016/j.cell.2025.09.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025. Verfasst von Aya Ludin und 43 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Onc…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Immunotherapy, Melanoma, Tumor Microenvironment. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, Melanoma Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell-mediated tumor killing underlies immunotherapy success. Here, we used long-term in vivo imaging and high-resolution spatial transcriptomics of zebrafish endogenous melanoma, as well as multiplex imaging of human melanoma, to identify domains facilitating the immune response during immunotherapy. We identified cancer regions of antigen presentation and T cell engagement and retention (CRATERs) as pockets at the stroma-melanocyte boundaries of zebrafish and human melanoma. CRATERs are rich in antigen-recognition molecules, harboring the highest density of CD8+ T cells in tumors. In zebrafish, CD8+ T cells formed prolonged interactions with melanoma cells within CRATERs, characteristic of antigen recognition. Following immunostimulatory treatment, CRATERs expanded, becoming the major sites of activated CD8+ T cell accumulation and tumor killing. In humans, elevation in CRATER density in biopsies following immune checkpoint blockade (ICB) therapy correlated with a clinical response to therapy. CRATERs are structures that show active tumor killing and may be useful as a diagnostic indicator for immunotherapy success.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesImmunotherapyMelanomaTumor MicroenvironmentAnimalsZebrafishHumansImmune Checkpoint InhibitorsCell Line, TumorAntigen Presentation

Stichwörter der Autor:innen

CD8+ T cellscancerimmune responseimmunotherapymelanomazebrafish

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Harvard Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
  • Harvard Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA 02138, USA.
  • Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA; Laboratory of Systems Pharmacology, Department of Systems Biology,…
  • Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • Melanoma Research Alliance
  • Human Frontier Science Program
  • Cycle for Survival
  • National Institutes of Health

Zitieren

APA

Ludin, A., Stirtz, G. L., Tal, A., Nirmal, A. J., Pfaff, K. L., Manos, M., Besson, N., Eskndir, N., Porter, B., Jones, S. M., Faulkner, H. M., Gong, Q., Liu, S., Barrera, I., Wu, L., Pessoa Rodrigues, C., Sahu, A., Jerison, E., Alessi, J. V., …, & Zon, L. I. (2025). CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success. Cell. https://doi.org/10.1016/j.cell.2025.09.021

Vancouver

Ludin A, Stirtz GL, Tal A, Nirmal AJ, Pfaff KL, Manos M, et al. CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success. Cell. 2025. doi:10.1016/j.cell.2025.09.021

BibTeX
@article{Ludin2025,
  author = {Ludin, Aya and Stirtz, Georgia L and Tal, Asaf and Nirmal, Ajit J and Pfaff, Kathleen L and Manos, Michael and Besson, Naomi and Eskndir, Nebiyat and Porter, Billie and Jones, Stephanie M and Faulkner, Hannah M and Gong, Qiyu and Liu, Sophia and Barrera, Irving and Wu, Lijian and Pessoa Rodrigues, Cecilia and Sahu, Aditi and Jerison, Elizabeth and Alessi, Joao V and Ricciuti, Biagio and Richardson, Douglas S and Weiss, Jodi D and Moreau, Hadley M and Stanhope, Meredith E and Afeyan, Alexander B and Sefton, James and McCall, Wyatt D and Formato, Emily and Yang, Song and Zhou, Yi and Hoytema van Konijnenburg, David P and Cole, Hannah L and Cordova, Miguel and Deng, Liang and Rajadhyaksha, Milind and Quake, Stephen R and Awad, Mark M and Chen, Fei and Wucherpfennig, Kai W and Sorger, Peter K and Hodi, F Stephen and Rodig, Scott J and Murphy, George F and Zon, Leonard I},
  title = {CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success},
  journal = {Cell},
  year = {2025},
  doi = {10.1016/j.cell.2025.09.021}
}
Kostenlos starten →